VAV2 and diabetes mellitus: We have shown that the inhibition of Vav2 by its pharmacological inhibitor EHop, in addition to regulating diabetes-induced activation of Rac1-Nox2, also prevents mitochondrial damage, vascular leakage and capillary cell apoptosis.